CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA MedWatch Safety Alerts
Original article

Convenience Kit Correction: Medline Issues Correction for Kits Containing Huons Lidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose Injection

RegulatoryLidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose InjectionNegative
AI Analysis

Summary

Medline is issuing a correction to convenience kits by removing recalled Lidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose Injection components supplied by Huons from affected kits.

Outcome Details

Product correction - removal of recalled components from convenience kits

Importance:2/10
Sentiment:
-0.50
product_recallcorrectionsafetymedical_device

Read the original article

Published by FDA MedWatch Safety Alerts on August 3, 2026 4:00 AM

Read Original